Olfr884 is an olfactory receptor, which is a member of the GPCR family predominantly found in olfactory sensory neurons. These receptors are key to the sense of smell, as they detect and bind specific odorant molecules, initiating a cascade of intracellular events that lead to the neuronal response and perception of odors. The function of Olfr884, like other olfactory receptors, involves a complex interplay of molecular interactions and signaling pathways that are finely tuned to respond to a diverse array of chemical stimuli.
The potential inhibition of Olfr884 involves either direct binding and inhibition of the receptor or, more likely, indirect effects on the receptor's function through modulation of associated signaling pathways. Given the specificity of olfactory receptors and the diversity of odorant molecules they respond to, identifying direct inhibitors is challenging. Therefore, the focus is often on indirect inhibition, achieved by targeting the signaling pathways and cellular processes that influence GPCR function. For instance, the modulation of second messenger systems, such as cAMP, or the interaction with other neurotransmitter systems that converge on GPCR pathways, can have downstream effects on the function of olfactory receptors, including Olfr884. In the case of Olfr884, indirect inhibitors can include compounds that affect neurotransmitter levels or receptor sensitivities, such as those influencing dopamine or serotonin signaling. These compounds, typically used for their effects on the central nervous system, can indirectly impact the function of Olfr884 by altering the overall signaling landscape within olfactory neurons. By modulating the levels of neurotransmitters or the activity of their receptors, these inhibitors can influence GPCR-mediated signaling cascades, which are integral to the function of olfactory receptors.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Aripiprazole | 129722-12-9 | sc-207300 sc-207300A sc-207300B | 100 mg 1 g 5 g | $179.00 $212.00 $1037.00 | 3 | |
Aripiprazole acts as a partial agonist at dopamine D2 receptors, which can lead to reduced dopamine signaling. This reduction in dopamine signaling could indirectly inhibit Olfr884 by modulating GPCR signaling pathways within olfactory neurons. | ||||||
S(−)-Carbidopa | 28860-95-9 | sc-200749 sc-200749A | 25 mg 100 mg | $96.00 $275.00 | 5 | |
Carbidopa inhibits aromatic L-amino acid decarboxylase, reducing dopamine synthesis. This can indirectly inhibit Olfr884 by decreasing dopamine levels, thereby modulating GPCR signaling in olfactory neurons. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine is a dopamine antagonist that can indirectly inhibit Olfr884 by altering dopamine signaling, which may affect GPCR-mediated pathways in olfactory sensory neurons. | ||||||
Clozapine | 5786-21-0 | sc-200402 sc-200402A sc-200402B sc-200402C | 50 mg 500 mg 5 g 10 g | $69.00 $364.00 $2500.00 $4100.00 | 11 | |
Clozapine, an atypical antipsychotic, acts on multiple neurotransmitter receptors including dopamine and serotonin receptors. Its broad receptor profile might indirectly inhibit Olfr884 by modulating GPCR signaling pathways in the olfactory system. | ||||||
Haloperidol | 52-86-8 | sc-507512 | 5 g | $190.00 | ||
Haloperidol is a D2 dopamine receptor antagonist. By inhibiting dopamine receptors, it can indirectly affect Olfr884 function by altering GPCR signaling pathways within olfactory neurons. | ||||||
Levodopa | 59-92-7 | sc-205372 sc-205372A | 5 g 25 g | $54.00 $171.00 | 9 | |
Levodopa is a precursor to dopamine and can enhance dopamine levels. Elevated dopamine may indirectly inhibit Olfr884 by modulating dopamine receptor-mediated GPCR signaling in the olfactory system. | ||||||
Metoclopramide | 364-62-5 | sc-358363 | 100 g | $465.00 | 1 | |
Metoclopramide, a dopamine antagonist, can indirectly inhibit Olfr884 by affecting dopamine signaling pathways, which may influence GPCR-mediated responses in olfactory neurons. | ||||||
Olanzapine | 132539-06-1 | sc-212469 | 100 mg | $133.00 | 6 | |
Olanzapine, an atypical antipsychotic, has a broad affinity for various neurotransmitter receptors including dopamine and serotonin receptors. This may indirectly inhibit Olfr884 through modulation of GPCR signaling pathways. | ||||||
Risperidone | 106266-06-2 | sc-204881 sc-204881A sc-204881B sc-204881C | 10 mg 50 mg 1 g 5 g | $174.00 $719.00 $1020.00 $2040.00 | 1 | |
Risperidone acts as an antagonist at dopamine D2 receptors. This inhibition can indirectly affect Olfr884 by modulating dopamine receptor-mediated GPCR signaling in the olfactory system. | ||||||